Lataa...
Dendroaspis natriuretic peptide and the designer natriuretic peptide, CD-NP, are resistant to proteolytic inactivation
Designer natriuretic peptides (NPs) represent an active area of drug development. In canine and human studies, the designer natriuretic peptide CD-NP demonstrated more desirable therapeutic potential than recombinant B-type NP (BNP), which is known as nesiritide and is approved for treatment of acut...
Tallennettuna:
| Julkaisussa: | J Mol Cell Cardiol |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2011
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4855506/ https://ncbi.nlm.nih.gov/pubmed/21459096 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.yjmcc.2011.03.013 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|